{"id":"https://openalex.org/W78232097","doi":"https://doi.org/10.1007/s00277-004-0850-2","title":"Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantation.","display_name":"Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantation.","publication_year":2004,"publication_date":"2004-01-01","ids":{"openalex":"https://openalex.org/W78232097","doi":"https://doi.org/10.1007/s00277-004-0850-2","mag":"78232097","pmid":"https://pubmed.ncbi.nlm.nih.gov/15124679"},"language":"en","primary_location":{"id":"pmid:15124679","doi":"https://doi.org/10.1007/s00277-004-0850-2","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15124679","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of hematology","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109839741","display_name":"J. Casper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4665924","display_name":"University of Rostock","ror":"https://ror.org/03zdwsf69","country_code":"DE","type":"education","lineage":["https://openalex.org/I4665924"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"J Casper","raw_affiliation_strings":["University of Rostock, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Rostock, Germany","institution_ids":["https://openalex.org/I4665924"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111958435","display_name":"Wolfgang Ulrich Knauf","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W Knauf","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029182363","display_name":"IW Blau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I Blau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027302651","display_name":"Tapani Ruutu","orcid":"https://orcid.org/0000-0002-4010-8345","observed_orcids":["https://orcid.org/0000-0002-4010-8345"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Ruutu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080330116","display_name":"Liisa Volin","orcid":"https://orcid.org/0000-0002-9731-8335","observed_orcids":["https://orcid.org/0000-0002-9731-8335"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Volin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109278480","display_name":"H. Wandt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Wandt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110169216","display_name":"K. Sch\u00e4fer-Eckart","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Schafer-Eckart","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078900537","display_name":"Jerzy Ho\u0142owiecki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Holowiecki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042552205","display_name":"Sebastian Giebel","orcid":"https://orcid.org/0000-0002-4827-4401","observed_orcids":["https://orcid.org/0000-0002-4827-4401"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Giebel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065745451","display_name":"JOHAN ASCHAN","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Aschan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109747736","display_name":"A Zander","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Zander","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001646221","display_name":"Nicolaus Martin Kr\u00f6ger","orcid":"https://orcid.org/0000-0001-5103-9966","observed_orcids":["https://orcid.org/0000-0001-5103-9966"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Kroger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052598232","display_name":"Gottfried Doelken","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Doelken","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111607048","display_name":"M. Freund","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Freund","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8531,"has_fulltext":false,"cited_by_count":24,"citation_normalized_percentile":{"value":0.7263128,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"83 Suppl 1","issue":null,"first_page":"S70","last_page":"1"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/treosulfan","display_name":"treosulfan","score":1.0},{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":1.0},{"id":"https://openalex.org/keywords/conditioning-regimen","display_name":"conditioning regimen","score":0.9599999785423279},{"id":"https://openalex.org/keywords/allogeneic-stem-cell-transplantation","display_name":"allogeneic stem cell transplantation","score":0.9079999923706055},{"id":"https://openalex.org/keywords/hematopoietic-stem-cell-transplantation","display_name":"hematopoietic stem cell transplantation","score":0.703000009059906},{"id":"https://openalex.org/keywords/donor-chimerism","display_name":"donor chimerism","score":0.7129999995231628},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.9729999899864197},{"id":"https://openalex.org/keywords/non-hematologic-toxicity","display_name":"non-hematologic toxicity","score":0.8069999814033508},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.5659999847412109},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8709999918937683},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9229999780654907},{"id":"https://openalex.org/keywords/alkylating-agents","display_name":"alkylating agents","score":0.6240000128746033}],"concepts":[{"id":"https://openalex.org/C2779178397","wikidata":"https://www.wikidata.org/wiki/Q7838652","display_name":"Treosulfan","level":5,"score":0.9935150146484375},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.8012933731079102},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7216688990592957},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.6602399945259094},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5230109095573425},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4373425841331482},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4265543818473816},{"id":"https://openalex.org/C2780611847","wikidata":"https://www.wikidata.org/wiki/Q348922","display_name":"Busulfan","level":4,"score":0.4099481999874115},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.40345004200935364},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3794996738433838},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.353218138217926},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.21111679077148438},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.06639859080314636}],"mesh":[{"descriptor_ui":"D002066","descriptor_name":"Busulfan","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002066","descriptor_name":"Busulfan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D009190","descriptor_name":"Myelodysplastic Syndromes","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014184","descriptor_name":"Transplantation, Homologous","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D014184","descriptor_name":"Transplantation, Homologous","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D014740","descriptor_name":"Vidarabine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014740","descriptor_name":"Vidarabine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D017708","descriptor_name":"Leukocyte Transfusion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019172","descriptor_name":"Transplantation Conditioning","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D033581","descriptor_name":"Stem Cell Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:15124679","doi":"https://doi.org/10.1007/s00277-004-0850-2","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15124679","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of hematology","raw_type":"Clinical Trial"},{"id":"mag:78232097","doi":"https://doi.org/10.1007/s00277-004-0850-2","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15124679","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G1325623568","display_name":"Immunoglobulin Gene Arrangement/Expression in Leukemia","funder_award_id":"R01CA052259","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G1860110607","display_name":null,"funder_award_id":"CA 36401","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2317848681","display_name":"BCI2 Antisense Against Chemoresistance in Elderly AML","funder_award_id":"R21CA094552","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G243041616","display_name":"North Shore CCOP","funder_award_id":"U10CA035279","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G258994785","display_name":"Phase I Trials of Anti-Cancer Agents","funder_award_id":"U01CA076576","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2645941341","display_name":"Cancer and Leukemia Group B","funder_award_id":"U10CA003927","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G299718856","display_name":"LARG, A Novel Leukemia Associated Guanine Exhange Factor","funder_award_id":"K08CA090469","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3591778097","display_name":"Cancer and Leukemia Group B - Leukemia Correlative Sciences","funder_award_id":"U10CA101140","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4254236046","display_name":"CHILDRENS CANCER GROUP CHAIRMANS AWARD","funder_award_id":"U10CA013539","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G438107773","display_name":null,"funder_award_id":"CA-51001","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4956614918","display_name":null,"funder_award_id":"CA60419","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G556416980","display_name":"Cancer and Leukemia Group B","funder_award_id":"U10CA032291","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5667653552","display_name":"Cancer and Leukemia Group B","funder_award_id":"U10CA047577","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6161792148","display_name":"ALL therapy and developing brains: MRI measures, genetic factors and cognition","funder_award_id":"R01CA090246","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6289903943","display_name":"SLEEP, FATIGUE, AND DEXAMETHOSONE IN CHILDHOOD CANCER","funder_award_id":"R01NR007610","funder_id":"https://openalex.org/F4320337353","funder_display_name":"National Institute of Nursing Research"},{"id":"https://openalex.org/G6558193811","display_name":"CANCER AND LEUKEMIA GROUP B","funder_award_id":"U10CA031983","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6956671963","display_name":"PAAR-Pharmacogenomics of Anticancer Agents Research Group","funder_award_id":"U01GM061393","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G7121342158","display_name":"PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDREN","funder_award_id":"R01CA078224","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7124877490","display_name":"CANCER AND LEUKEMIA GROUP B","funder_award_id":"U10CA047545","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7490599067","display_name":"Cancer and Leukemia Group B","funder_award_id":"U10CA041287","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7715050869","display_name":"Cancer and Leukemia Group B - The Ohio State University","funder_award_id":"U10CA077658","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000887552","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA016058","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000904664","display_name":"Cancer Center Support Grant (CCSG)","funder_award_id":"P30CA021765","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337353","display_name":"National Institute of Nursing Research","ror":"https://ror.org/01y3zfr79"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2097419847","https://openalex.org/W1969684548","https://openalex.org/W2125695170","https://openalex.org/W3033833330","https://openalex.org/W2004164107","https://openalex.org/W2595019264","https://openalex.org/W2980336854","https://openalex.org/W1984432386","https://openalex.org/W2559359494","https://openalex.org/W3200351501"],"abstract_inverted_index":{"Recently,":[0],"the":[1,58,70,136,183],"water-soluble":[2],"bifunctional":[3],"alkylating":[4],"agent":[5,32],"treosulfan":[6,27,49,91],"demonstrated":[7,57],"broad":[8],"stem":[9],"cell":[10],"toxicity,":[11,81],"immunosuppressive":[12],"as":[13,15,75,77],"well":[14,21,76,155],"antileukemic":[16],"activity.":[17],"Due":[18],"to":[19,36,98,115,194],"its":[20],"known":[22],"low":[23,79],"non-hematologic":[24,80],"toxicity":[25,165],"profile,":[26],"was":[28,73,92,128,153,166],"considered":[29,193],"an":[30],"alternative":[31],"for":[33],"conditioning":[34,117,191],"prior":[35],"allogeneic":[37],"transplantation.":[38],"A":[39,63],"first":[40],"clinical":[41,202],"study,":[42],"combining":[43],"3":[44,95,99,103],"x":[45,52,96,100,104],"10":[46,97],"g/m2":[47],"of":[48,55,60,69,135,180,186],"with":[50],"5":[51],"30":[53],"mg/m2":[54],"fludarabine,":[56],"feasibility":[59],"this":[61,108],"conditioning.":[62],"fast,":[64],"reliable":[65],"and":[66,84,102,147,175,197,206],"complete":[67],"development":[68],"donor":[71,126],"hematopoiesis":[72],"evident":[74],"a":[78,88],"transplantation-related":[82],"mortality":[83],"relapse":[85],"rate.":[86],"In":[87,107],"second":[89],"study":[90,188],"escalated":[93],"from":[94,119],"12":[101],"14":[105],"g/m2.":[106],"protocol,":[109],"55":[110],"pts":[111,141,149],"(patients)":[112],"not":[113],"amenable":[114],"standard":[116],"suffering":[118],"various":[120],"hematological":[121],"malignancies":[122],"were":[123],"included.":[124],"Complete":[125],"chimerism":[127],"reached":[129],"by":[130],"day":[131],"28":[132],"in":[133,173,178,204],"80%":[134],"pts.":[137,181],"So":[138],"far,":[139],"8":[140],"(11%)":[142],"died":[143],"without":[144],"disease":[145],"progression":[146],"11":[148,201],"(20%)":[150],"relapsed.":[151],"Treosulfan":[152],"very":[154],"tolerated.":[156],"Especially":[157],"no":[158],"hepatic":[159],"VOD,":[160],"severe":[161],"cardiac":[162],"or":[163],"pulmonary":[164],"noted.":[167],"Acute":[168],"GvHD":[169,177],"(degrees":[170],"11-IV)":[171],"occurred":[172],"44%":[174],"chronic":[176],"45%":[179],"Considering":[182],"poor":[184],"prognosis":[185],"these":[187],"populations,":[189],"treosulfan-based":[190],"is":[192],"be":[195,209],"safe":[196],"efficient.":[198],"New":[199],"phase":[200],"protocols":[203],"AML":[205],"MDS":[207],"will":[208],"initiated.":[210]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}